- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04802434
Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder
November 20, 2023 updated by: Nicole Matthews, Ph.D., Southwest Autism Research & Resource Center
Randomized Controlled Trial of Strengthening Skills, A Multi-Component Behavioral Intervention to Increase Functional Independence During Aging in Autism Spectrum Disorder
The purpose of this study is to examine changes in adaptive functioning, quality of life, and prospective memory among adults with ASD (Autism Spectrum Disorder) who complete Strengthening Skills, a multi-faceted, behavioral intervention that combines the PEERS Social Skills program with cognitive compensation training, mindfulness-based emotional regulation, and support group components.
Participants and their study partners (e.g., spouse, parent, friend) will be randomly assigned to one of three groups: Strengthening Skills, PEERS only, or a delayed treatment control group.
The Strengthening Skills group will meet weekly for 3 hours for 16 weeks and will learn strategies for gaining and maintaining independence and emotion regulation.
Participants will also learn strategies from the PEERS Social Skills Program.
The PEERS only group will meet weekly for 1.5 hours for 16 weeks and will only learn strategies from the PEERS Social Skills Program.
The delayed treatment control group will participant in data collection at four time points over a 10-month wait period, after which, they will be enrolled into the Strengthening Skills Program.
Behavioral self-report data will be collected and a prospective memory assessment will be conducted before and after participation in the 16-week programs.
Behavioral self-report data will also be collected at remote 3- and 6-month follow-up visits.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tempe, Arizona, United States, 85281
- Arizona State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Meets criteria for autism or autism spectrum on a gold-standard diagnostic assessment (Autism Diagnostic Observation Schedule-2)
- Must have a study partner (e.g., parent, spouse, sibling, friend) willing and able to complete questionnaires at all four time points
- Must be willing to be randomized to a treatment or delayed treatment control group
- Must be able to attend at least 14 of the 16 weekly intervention sessions
- English speaking: Participants must be English-speaking because the screening and behavioral measures are in English (including the intelligence estimate), as well as the intervention content
Exclusion Criteria:
- Non-verbal participants will be excluded to ensure test compliance and increase sample homogeneity.
- Participants with IQ (intelligence quotient) scores lower than 70 will be excluded because the interventions were developed for individuals without intellectual disability.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strengthening Skills Program
Adults with ASD and their study partners (i.e., spouse, parent, other family member, or friend) will attend weekly 3 hour meetings for 16 weeks, during which, behavioral intervention strategies will be used to teach cognitive compensation and mindfulness-based emotion regulation skills.
Strategies from the PEERS Social Skills Program will also be taught.
Participants will be assigned homework assignments each week to practice skills they are learning in a real-world setting.
|
The Strengthening Skills Program is a new, multi-component intervention.
It includes three components: (1) Forming habits to compensate for the difficulties many adults with ASD have with thinking flexibly, planning, and time management.
It will emphasize habit-forming behaviors to compensate for weaknesses in functional skills by training on practical techniques; (2) Content from the PEERS Social Skills program to target social challenges, and (3) strategies derived from Mindfulness Based Stress Reduction to target emotion regulation.
PEERS® is a well-established social communication training program, initially developed for adolescents, and more recently extended to young adults with ASD.
Program content will be adapted slightly so as to be appropriate for older adults.
|
|
Active Comparator: PEERS Social Skills Program
Adults with ASD and their study partners (i.e., spouse, parent, other family member or friend) will attend weekly 1.5 hour meetings for 16 weeks, during which, behavioral intervention strategies will be used to teach skills for improving social relationships and handling social rejection.
Participants will be assigned homework assignments each week to practice skills they are learning in a real-world setting.
|
PEERS® is a well-established social communication training program, initially developed for adolescents, and more recently extended to young adults with ASD.
Program content will be adapted slightly so as to be appropriate for older adults.
|
|
No Intervention: Delayed Treatment Control Group
Participants in the delayed treatment control group will participate in a 10-month wait period, during which they will complete data collection procedures at three time points (Baseline, Post, and 6-month follow-up).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change from Baseline in Adaptive Functioning on the Adaptive Behavior Assessment System, Third Edition (ABAS-3)
Time Frame: Post-Intervention (16 weeks); 3-month follow-up; 6-month follow-up
|
The ABAS-3 Adult Form is a self and other-report questionnaire designed specifically for adult participants (ages 16 to 89), which yields standard scores (Mean = 100, Standard Deviation = 15) in three adaptive domains (i.e., Conceptual, Social, and Practical) and a General Adaptive Composite (GAC).
Scores range from 40 to 120 with higher scores indicating better adaptive functioning.
|
Post-Intervention (16 weeks); 3-month follow-up; 6-month follow-up
|
|
Mean Change from Baseline in Self-reported Quality of Life on the World Health Organization's Brief Quality of Life assessment (WHOQOL-BREF)
Time Frame: Post-Intervention (16 weeks); 3-month follow-up; 6-month follow-up
|
The WHOQOL-BREF is an abbreviated version of the World Health Organization's Quality of Life assessment (WHOQOL-100).
26-item self-report questionnaire that yields an Overall Quality of Life and General Health score and four quality of life domain scores: physical health, psychological, social relationships, and environment.
Scores range from 0 to 100 on all domains, with higher scores indicating better quality of life.
|
Post-Intervention (16 weeks); 3-month follow-up; 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change from Baseline in Prospective Memory on the Royal Prince Alfred Prospective Memory Test
Time Frame: Post-Intervention (16 weeks)
|
4-item behavioral measure of prospective memory.
Each item has a maximum score of three points, with a total possible score of 12 points.
Scores range from 0 to 12, with higher scores indicating better prospective memory.
|
Post-Intervention (16 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nicole L Matthews, Ph.D., Southwest Autism Research & Resource Center
- Principal Investigator: Brittany B Braden, Ph.D., Arizona State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Actual)
April 30, 2023
Study Completion (Actual)
April 30, 2023
Study Registration Dates
First Submitted
March 12, 2021
First Submitted That Met QC Criteria
March 12, 2021
First Posted (Actual)
March 17, 2021
Study Record Updates
Last Update Posted (Actual)
November 22, 2023
Last Update Submitted That Met QC Criteria
November 20, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00011585
- W81XWH-20-1-0171 (Other Grant/Funding Number: Department of Defense CDMRP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All individual participant data (IPD) that underlie results in a publication will be available upon request to approved researchers.
IPD Sharing Time Frame
Data will be available upon request starting 6 months after publication and will remain available for 2 years.
IPD Sharing Access Criteria
Data requests should be submitted to Dr. Blair Braden at bbbraden@asu.edu
and must include study aims and purpose and a detailed analysis plan describing how the data will be used.
Requests will be reviewed by Dr. Braden and access to the data will be made available through a secure link to download the requested data.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Healing Hope InternationalKurve Technology Inc.Enrolling by invitationNeurodevelopmental Disorders | Autism Spectrum Disorder | Autistic Disorder | Autism Spectrum Disorder (ASD) | Autistic Disorders Spectrum | Autism Spectrum Disorder High-Functioning | Autism Spectrum Disorder With Impaired Functional Language | Autistic Disorder of Childhood Onset With Full Syndrome and other conditionsUnited States
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on Strengthening Skills Program
-
Cairo UniversityNot yet recruitingSacroiliac DysfunctionEgypt
-
Riphah International UniversityRecruitingAthletic Performance and Injury RiskPakistan
-
RTI InternationalNew Jersey Prevention Network; RWJBarnabas Health Institute for Prevention...RecruitingSubstance-Related Disorders | Adverse Childhood ExperiencesUnited States
-
University of LiegeRecruitingAnkle Sprain | Chronic Ankle Instability, CAIBelgium
-
University of Kansas Medical CenterCompletedUpper Extremity Injuries | Elbow Injuries | Sprain Ulnar Collateral Ligament | Strain of Ulnar Collateral Ligament | Complete Tear Ulnar Collateral LigamentUnited States
-
Universidad Nacional de ColombiaCompletedPatellofemoral Pain SyndromeColombia
-
Kaohsiung Veterans General Hospital.Not yet recruitingKnee Osteoarthritis (Knee OA)
-
Boston CollegeChristian Alliance for Orphans; Helping Children Worldwide; Child Reintegration...CompletedEvaluation of a Family Strengthening Program Evaluation in Sierra Leone to Prevent Family SeparationParent-Child Relations | Parenting | Emotion Regulation | Economic ProblemsSierra Leone
-
Creighton UniversityNational Institutes of Health (NIH); National Institute of General Medical... and other collaboratorsCompletedACL TearsUnited States
-
University of RoehamptonUniversity of Malaya; Universidad Complutense de Madrid; Saglik Bilimleri Universitesi and other collaboratorsRecruitingAnxiety | Depression in AdolescenceMalaysia